These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 3500471)

  • 1. Anti-idiotype immunization of cancer patients: modulation of the immune response.
    Herlyn D; Wettendorff M; Schmoll E; Iliopoulos D; Schedel I; Dreikhausen U; Raab R; Ross AH; Jaksche H; Scriba M
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8055-9. PubMed ID: 3500471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.
    Herlyn D; Ross AH; Iliopoulos D; Koprowski H
    Eur J Immunol; 1987 Nov; 17(11):1649-52. PubMed ID: 3500066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory activity of monoclonal anti-idiotypic antibody to anti-colorectal carcinoma antibody CO17-1A in animals and patients.
    Herlyn D; Harris D; Zaloudik J; Sperlagh M; Maruyama H; Jacob L; Kieny MP; Scheck S; Somasundaram R; Hart E
    J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):303-11. PubMed ID: 8061902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-idiotypic antibody (ab2) vaccines: coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients.
    Birebent B; Koido T; Mitchell E; Li W; Somasundaram R; Purev E; Hoey D; Mastrangelo M; Maguire H; Harris DT; Nair S; Cai E; Herlyn D
    J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R27-33. PubMed ID: 11768621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A.
    Wettendorff M; Iliopoulos D; Tempero M; Kay D; DeFreitas E; Koprowski H; Herlyn D
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3787-91. PubMed ID: 2786203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen.
    Bhattacharya-Chatterjee M; Mukerjee S; Biddle W; Foon KA; Köhler H
    J Immunol; 1990 Oct; 145(8):2758-65. PubMed ID: 1698862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-idiotypic antibodies to monoclonal antibody CO17-1A.
    Herlyn D; Sears H; Iliopoulos D; Lubeck M; Douillard JY; Sindelar W; Tempero M; Mellstedt H; Maher M; Koprowski H
    Hybridoma; 1986 Jul; 5 Suppl 1():S51-8. PubMed ID: 3488951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cancer patients' immune responses by anti-idiotypic antibodies.
    Herlyn D; Wettendorff M; Koprowski H
    Int Rev Immunol; 1989; 4(4):347-57. PubMed ID: 2519932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-idiotype cancer vaccines: pre-clinical and clinical studies.
    Herlyn D; Benden A; Kane M; Somasundaram R; Zaloudik J; Sperlagh M; Marks G; Hart E; Ralph C; Wettendorff M
    In Vivo; 1991; 5(6):615-23. PubMed ID: 1810448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the anti-idiotypic responses generated by antibodies to a protein and a hapten: a common interspecies idiotype on antibodies against human albumin induces an idiotypic network in rabbits.
    Comacchio RM; Bradley J; Hohmann AW
    Immunol Cell Biol; 1996 Feb; 74(1):72-80. PubMed ID: 8934657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific detection of antibodies in cancer patients following immunotherapy with anti-idiotype.
    Wettendorff M; Iliopoulos D; Schmoll E; Koprowski H; Herlyn D
    J Immunol Methods; 1989 Jan; 116(1):105-15. PubMed ID: 2783712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiotype vaccines against human T cell leukemia. II. Generation and characterization of a monoclonal idiotype cascade (Ab1, Ab2, and Ab3).
    Bhattacharya-Chatterjee M; Chatterjee SK; Vasile S; Seon BK; Kohler H
    J Immunol; 1988 Aug; 141(4):1398-403. PubMed ID: 2899603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients treated with a monoclonal antibody (ab1) to the colorectal carcinoma antigen 17-1A develop a cellular response (DTH) to the "internal image of the antigen" (ab2).
    Mellstedt H; Frödin JE; Biberfeld P; Fagerberg J; Giscombe R; Hernandez A; Masucci G; Li SL; Steinitz M
    Int J Cancer; 1991 May; 48(3):344-9. PubMed ID: 2040527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-idiotype and recombinant antigen in immunotherapy of colorectal cancer.
    Herlyn D; Somasundaram R; Zaloudik J; Jacob L; Harris D; Kieny MP; Sears H; Mastrangelo M
    Cell Biophys; 1994; 24-25():143-53. PubMed ID: 7736518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-idiotypic antibodies bear the internal image of a human tumor antigen.
    Herlyn D; Ross AH; Koprowski H
    Science; 1986 Apr; 232(4746):100-2. PubMed ID: 3952496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
    Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D
    Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.
    Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR
    Cancer Res; 1998 Dec; 58(23):5447-52. PubMed ID: 9850078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of anti-idiotypic (ab2) and anti-anti-idiotypic (ab3) antibodies in patients treated with the mouse monoclonal antibody 17-1A (ab1). Relation to the clinical outcome--an important antitumoral effector function?
    Frödin JE; Faxas ME; Hagström B; Lefvert AK; Masucci G; Nilsson B; Steinitz M; Unger P; Mellstedt H
    Hybridoma; 1991 Aug; 10(4):421-31. PubMed ID: 1937495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy?
    Fagerberg J; Frödin JE; Ragnhammar P; Steinitz M; Wigzell H; Mellstedt H
    Cancer Immunol Immunother; 1994 Mar; 38(3):149-59. PubMed ID: 8124683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiotype-anti-idiotype regulation. I. Immunization with a levan-binding myeloma protein leads to the appearance of auto-anti-(anti-idiotype) antibodies and to the activation of silent clones.
    Bona CA; Heber-Katz E; Paul WE
    J Exp Med; 1981 Apr; 153(4):951-67. PubMed ID: 7252415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.